Freiburg
Germany
47
2025-01-16
The entities that hold a legal rights for patent applications filed by inventor Woltering Thomas:
Thomas Woltering from Freiburg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES
#2 | 2020-10-01BACE1 inhibitors
#3 | 2019-11-21Pyridyl-triazabicycles
#4 | 2019-11-14MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES
#5 | 2019-11-07BACE1 inhibitors
#6 | 2018-11-08BACE1 inhibitors
#7 | 2018-11-01Pyridyl-triazabicycles
#8 | 2018-08-23MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES
#9 | 2018-07-12Pyridyl-triazabicycles
#10 | 2018-03-01BACE1 inhibitors
#11 | 2017-11-23BACE1 inhibitors
#12 | 2017-08-102,2,2-trifluoroethyl-thiadiazines
#13 | 2017-06-22MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF AUTISTIC DISORDERS
#14 | 2017-02-09MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES
#15 | 2016-11-035-aryl-1-imino-1-oxo-[1,2,4]thiadiazines
#16 | 2016-04-14BACE1 inhibitors
#17 | 2016-02-25BACE1 inhibitors
#18 | 2015-12-31FLUORO-[1,3]OXAZINES AS BACE1 INHIBITORS
#19 | 2015-09-10MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF AUTISTIC DISORDERS
#20 | 2015-05-215-amino[1,4]thiazines as BACE 1 inhibitors
#21 | 2015-01-29Fluoromethyl-5,6-dihydro-4H-[1,3]OXAZINES
#22 | 2014-11-131,4,5,6-TETRAHYDRO-PYRIMIDIN-2-YLAMINE COMPOUNDS
#23 | 2014-03-20Halogen-alkyl-1,3 oxazines as BACE1 and/or BACE2 inhibitors
#24 | 2014-02-132,5,6,7-Tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
#25 | 2013-08-013-AMINO-5-PHENYL-56-DIHYDRO-2H-[1,4]OXAZINES
#26 | 2013-04-04Methods for the preparation of 5-[2-[7 (trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo [1,5-A]pyrimidin-3-yl[ethynyl]-2-pyridinamine
#27 | 2013-03-21N-(3-(2-amino-6,6-difluoro-4,4A,5,6,7,7A-hexahydro-cyclopenta[E][1,3]oxazin-4-yl)-phenylamides as BACE1 inhibitors
#28 | 2013-01-10Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
#29 | 2012-11-221,3-oxazines as BACE 1 and/or BACE2 inhibitors
#30 | 2012-10-041,4-Oxazepines as BACE1 and/or BACE2 inhibitors
#31 | 2012-09-201,4-oxazepines as BACE1 and/or BACE2 inhibitors
#32 | 2012-08-233-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES
#33 | 2012-07-191,4 oxazines as BACE1 and/or BACE2 inhibitors
#34 | 2012-05-31Quinolines
#35 | 2012-02-091,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
#36 | 2011-12-222,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
#37 | 2011-06-162-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides
#38 | 2011-02-243-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
#39 | 2010-03-115-substituted benzoxazines
#40 | 2010-03-116-substituted benzoxazines
#41 | 2009-09-172-aminoquinolines
#42 | 2009-09-102-aminoquinolines
#43 | 2009-09-102-aminoquinoline derivatives
#44 | 2009-09-102-aminoquinolines
#45 | 2009-09-102-aminoquinolines
#46 | 2009-08-204,5-dihydro-oxazol-2-yl amine derivatives
#47 | 2009-04-02QUINOLINES
29866 ⎘